Sequenom regains compliance with Nasdaq listing requirements

By Lisa Kerner

Charlotte, N.C., June 28 - Sequenom, Inc. said the Listing Qualifications Panel of The Nasdaq Stock Market informed the company it had regained compliance with the minimum bid price requirement for continued listing on The Nasdaq National Market.

In addition, Sequenom has regained compliance with Nasdaq's shareholders' minimum equity requirement following the company's $33 million private placement of common stock and warrants.

Sequenom was granted an exception until Aug. 15 to file its 10-Q with the Securities and Exchange Commission for the quarter ending June 30.

San Diego-based Sequenom provides genetic analysis products used in biomedical research, molecular medicine and agricultural applications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.